44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Pulmonology

Sign up for email alert when new content gets added: Sign up

Pneumothorax in chronically ventilated neuromuscular and chest wall restricted patients: A case series

Author(s): Andrea HS Loewen, Raymond Tye, Kristin L Fraser, Karen P Rimmer.

INTRODUCTION: Pneumothorax occurs in chronically ventilated neuromuscular and chest wall-restricted patients. Non-invasive home mechanical ventilation (HMV) and airway clearance techniques are standard care, but are perceived to put patients at increased risk of pneumothorax. Malnutrition as reflected by low body mass index was identified as an association with pneumothorax in this case series. METHODS: Retrospective chart review of six cases of pneumothorax in patients with neuromuscular and chest wall diseases receiving chronic HMV. RESULTS: Six cases were reviewed. Median duration of HMV at time of the pneumothorax was 3 years (range 0.25 to 9 years). Five patients used airway clearance techniques. The mean forced vital capacity (FVC) was 1.0L (27% predicted). Patients had a low mean body mass index (BMI) of 16 ± 3 kg/m2. Five of 6 patients required chest drain and 4 of 6 had recurrent pneumothoraxes. One patient received chemical pleurodesis. CONCLUSION: Pneumothorax occurs in neuromuscular patients receiving HMV and using airway clearance techniques. Management can include reducing ventilator pressure settings, holding airway clearance techniques and use of a chest drain. Chemical or surgical pleurodesis were felt to be high risk. Recurrence of pneumothorax was common. Low BMI in this case series raises the possible association between malnutrition and risk of pneumothorax in patients receiving HMV.


PDF
 
Google Scholar citation report
Citations : 117

Journal of Pulmonology received 117 citations as per Google Scholar report

pulsus-health-tech
Top